RESEARCH TRIANGLE PARK, N.C., Sept. 7, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq: TZYM), today announced that Vipin Garg, President and CEO and Richard Eisenstadt, CFO will present at the following investor conferences in September:
RESEARCH TRIANGLE PARK, N.C., Sept. 7, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq: TZYM), today announced that Vipin Garg, President and CEO and Richard Eisenstadt, CFO will present at the following investor conferences in September:
